Furthermore, our results strongly suggested that decrease or loss of NR2E3 could trigger epigenetic reprogramming promoting susceptibility to and development of liver cancer such that inhibition of LSD1 or modulation of NR2E3 function can be a novel prevention or therapeutic strategy in liver cancer development, in part, by regulating expression of tumor suppressive genes. Here, KDM1A is linked to neoplasm.